145 related articles for article (PubMed ID: 21956799)
1. Characterization of melanocortin receptors.
Goetz AS; Ignar DM
Curr Protoc Pharmacol; 2003 Nov; Chapter 1():Unit1.28. PubMed ID: 21956799
[TBL] [Abstract][Full Text] [Related]
2. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
3. γ₂-Melanocyte stimulation hormone (γ₂-MSH) truncation studies results in the cautionary note that γ₂-MSH is not selective for the mouse MC3R over the mouse MC5R.
Joseph CG; Yao H; Scott JW; Sorensen NB; Marnane RN; Mountjoy KG; Haskell-Luevano C
Peptides; 2010 Dec; 31(12):2304-13. PubMed ID: 20833220
[TBL] [Abstract][Full Text] [Related]
4. Neural melanocortin receptors are differentially expressed and regulated by stress in rat hypothalamic-pituitary-adrenal axis.
Wachira SJ; Hughes-Darden CA; Nicholas HB; Taylor CV; Robinson TJ
Cell Mol Biol (Noisy-le-grand); 2004 Sep; 50(6):703-13. PubMed ID: 15641161
[TBL] [Abstract][Full Text] [Related]
5. The interaction of MC3R and MC4R with MRAP2, ACTH, α-MSH and AgRP in chickens.
Zhang J; Li X; Zhou Y; Cui L; Li J; Wu C; Wan Y; Li J; Wang Y
J Endocrinol; 2017 Aug; 234(2):155-174. PubMed ID: 28512117
[TBL] [Abstract][Full Text] [Related]
6. Dimerization of melanocortin receptor 1 (MC1R) and MC5R creates a ligand-dependent signal modulation: Potential participation in physiological color change in the flounder.
Kobayashi Y; Hamamoto A; Takahashi A; Saito Y
Gen Comp Endocrinol; 2016 May; 230-231():103-9. PubMed ID: 27080548
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor.
Carotenuto A; Merlino F; Cai M; Brancaccio D; Yousif AM; Novellino E; Hruby VJ; Grieco P
J Med Chem; 2015 Dec; 58(24):9773-8. PubMed ID: 26599352
[TBL] [Abstract][Full Text] [Related]
8. Key amino acid residue in Melanocortin-1 receptor (melanocyte α-MSH receptor) for ligand selectivity.
Yang Y; Chen M; Ventro G; Harmon CM
Mol Cell Endocrinol; 2017 Oct; 454():69-76. PubMed ID: 28579117
[TBL] [Abstract][Full Text] [Related]
9. Minimization of MC1R selectivity by modification of the core structure of alpha-MSH-ND.
Lim S; Li S; Lee C; Yoon C; Baik J; Lee W
Chem Biol; 2001 Sep; 8(9):857-70. PubMed ID: 11564554
[TBL] [Abstract][Full Text] [Related]
10. Novel binding motif of ACTH analogues at the melanocortin receptors.
Yang Y; Hruby VJ; Chen M; Crasto C; Cai M; Harmon CM
Biochemistry; 2009 Oct; 48(41):9775-84. PubMed ID: 19743876
[TBL] [Abstract][Full Text] [Related]
11. Biphasic effect of melanocortin agonists on metabolic rate and body temperature.
Lute B; Jou W; Lateef DM; Goldgof M; Xiao C; Piñol RA; Kravitz AV; Miller NR; Huang YG; Girardet C; Butler AA; Gavrilova O; Reitman ML
Cell Metab; 2014 Aug; 20(2):333-45. PubMed ID: 24981835
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activity of neural melanocortin receptors.
Tao YX; Huang H; Wang ZQ; Yang F; Williams JN; Nikiforovich GV
Methods Enzymol; 2010; 484():267-79. PubMed ID: 21036237
[TBL] [Abstract][Full Text] [Related]
13. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of cAMP-mediated gene transcription and ligand selectivity by MC3R and MC4R melanocortin receptors.
Lee EJ; Lee SH; Jung JW; Lee W; Kim BJ; Park KW; Lim SK; Yoon CJ; Baik JH
Eur J Biochem; 2001 Feb; 268(3):582-91. PubMed ID: 11168397
[TBL] [Abstract][Full Text] [Related]
15. Distinct binding and signaling activity of Acthar Gel compared to other melanocortin receptor agonists.
Huang YJ; Galen K; Zweifel B; Brooks LR; Wright AD
J Recept Signal Transduct Res; 2021 Oct; 41(5):425-433. PubMed ID: 32938265
[TBL] [Abstract][Full Text] [Related]
16. Discovery and in vivo evaluation of new melanocortin-4 receptor-selective peptides.
Nijenhuis WA; Kruijtzer JA; Wanders N; Vrinten DH; Garner KM; Schaaper WM; Meloen RH; Gispen WH; Liskamp RM; Adan RA
Peptides; 2003 Feb; 24(2):271-80. PubMed ID: 12668212
[TBL] [Abstract][Full Text] [Related]
17. Development of potent selective competitive-antagonists of the melanocortin type 2 receptor.
Bouw E; Huisman M; Neggers SJ; Themmen AP; van der Lely AJ; Delhanty PJ
Mol Cell Endocrinol; 2014 Aug; 394(1-2):99-104. PubMed ID: 25017734
[TBL] [Abstract][Full Text] [Related]
18. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].
Ying Y; Lan XP; Tian YP
Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a putative alpha-MSH antagonist 153N-6 at melanocortin receptor subtypes by radioligand binding.
Chhajlani V
Peptides; 1996; 17(2):349-51. PubMed ID: 8801544
[TBL] [Abstract][Full Text] [Related]
20. Role of alpha-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation.
Lasaga M; Debeljuk L; Durand D; Scimonelli TN; Caruso C
Peptides; 2008 Oct; 29(10):1825-35. PubMed ID: 18625277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
